Biphasic release of the alarmin high mobility group box 1 protein early after trauma predicts poor clinical outcome
Critical Care Medicine Jul 18, 2019
Ottestad W, et al. - In this prospective single-center observational investigation including 136 trauma patients, researchers focused on high mobility group box 1 protein concentration kinetics with high time resolution during the first hours following trauma in individual patients as well as determined the link with the outcome. Repeated samples were analyzed using enzyme-linked immunosorbent assay to determine total plasma high mobility group box 1 protein levels. The primary outcome measure was ventilator-free days. Findings revealed that the release of high mobility group box 1 protein occurred in two consecutive phases. The outcome was significantly predicted by only the second high mobility group box 1 protein wave. High mobility group box 1 protein-specific antagonist therapy might be hypothetically beneficial in patients with a high high mobility group box 1 protein level between 3 and 6 hours post-trauma.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries